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Tuesday, May 17, 2022
During this COVID-19 pandemic and other future events, the CDM has been and will continue
to be a source of reliable information, education and models for mitigation, preparedness,
response, and recovery. We hope this informational document has helped provide you
filtered and actionable information. As the pace of new information and changes occur, we
will evaluate the current once per week to determine if this information should be provided on
a more frequent basis.

David Markenson, M.D., M.B.A.
Director
Center for Disaster Medicine

COVID-19 Statistic

Total Cases

Total Deaths

Total Vaccine Doses
Admin.

Worldwide

521,911,280

6,265,362

11,413,118,565

United States

82,613,628

999,841

579,643,738

New Jersey

2,325,525

33,553

17,387,066

New York

5,315,176

68,670

39,592,667

Connecticut

789,933

10,914

7,703,368

Information as of 5/17/22 at 0600 EDT. Source: https://coronavirus.jhu.edu/map.html

United States COVID-19 Case Map / GIS

Center for Disaster Medicine Updates
•
•
•
•

Coordinating and overseeing COVID-19 screenings at NYMC campus.
Continue to partner with local organizations such as Westchester Department of Emergency
Services and Westchester Medical Center to ensure ongoing collaboration with all public
safety agencies.
Coordinating volunteers to support local public health response to COVID-19.
Conducting research and analysis of current events and COVID-19 response to identify
strengths and areas for improvement in other regions.

•
•
•
•

Updating and developing new programs to provide enhanced education on public health
emergencies including pandemics.
Exploring course development opportunities in infection prevention and control for frontline
responders in the hospital and in the field.
Serving as a source of information for COVID-19 related concerns or questions regarding
public health, emergency medical service (EMS), public safety and healthcare response.
Local networking and pandemic response analysis for New York’s tri-state area, using firstperson experiences to highlight current trends.

The White House
The official website of the White House will deliver updated information as the country grapples
with converging crises. This will include actions to control the COVID-19 pandemic, provide
economic relief, tackle climate change, and advance racial equity and civil rights, as well as
immediate actions to reform our immigration system and restore America’s standing in the world.
This website will provide all information in one central location.
•

President Biden believes that Americans deserve to feel safe no matter where they live,
and he is committed to using every tool at his disposal to fight violent crime. As the
cornerstone of the comprehensive gun crime reduction agenda he issued in June 2021,
President Biden called on cities and states to dedicate American Recue Plan state and
local funding to proven strategies that will make our communities safer – including by
putting more police officers on the beat for accountable community policing, expanding
evidence-based community violence intervention programs, and preventing crime by
making our neighborhoods stronger with more educational and economic opportunities.
President Biden is announcing that $10 billion in American Rescue Plan funds have
been committed to public safety – including at least $6.5 billion in State and Local funds
committed by more than half of states and more than 300 communities across the
country, who have answered the President’s call. Along with ongoing state and local
support from the Justice Department, American Rescue Plan investments made
2021 among the largest single-year commitments of federal resources for state and local
law enforcement and public safety on record. https://www.whitehouse.gov/briefingroom/statements-releases/2022/05/13/fact-sheet-president-biden-issues-call-for-stateand-local-leaders-to-dedicate-more-american-rescue-plan-funding-to-make-ourcommunities-safer-and-deploy-these-dollars-quickly/

https://www.whitehouse.gov
COVID-19 Website
On March 30, 2022, Biden Administration Launched COVID.gov, a New One-Stop Shop Website
for Vaccines, Tests, Treatments, Masks, and the Latest COVID-19 Information- a new website
was launched in an effort to consolidate information for consumers.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/03/30/fact-sheet-bidenadministration-launches-covid-gov-a-new-one-stop-shop-website-for-vaccines-tests-treatmentsmasks-and-the-latest-covid-19-information/
Health and Human Services (HHS)
•

At the second Global COVID-19 Summit, President Biden announced that the BidenHarris administration, through the U.S. National Institutes of Health (NIH), has licensed
11 COVID-19 research tools and early-stage vaccine and diagnostic candidates to the
Medicines Patent Pool (MPP) through the World Health Organization’s COVID-19
Technology Access Pool (C-TAP). The licenses will allow manufacturers from all around
the world to work with MPP and C-TAP to use these technologies for the potential

development of COVID-19 vaccines, treatments, and diagnostics to benefit people living
in low- and middle-income countries. Included in the technologies licensed is the SARSCoV-2 stabilized spike protein—a patented invention included in multiple COVID-19
vaccines. C-TAP aims to boost global supply of vaccines, treatments, and diagnostics
for COVID-19 by facilitating the sharing of intellectual property, knowledge, and data
with quality-assured manufacturers that have capacity to scale up production. NIH
scientists regularly make discoveries—both patented and unpatented—that can be
transferred to the private sector for further research and development and eventual
commercialization. While NIH has already granted nonexclusive licenses to companies
for use of the SARS-CoV-2 stabilized spike protein, making this and other technologies
available through C-TAP will facilitate even wider access.
https://www.hhs.gov/about/news/2022/05/12/nih-licenses-covid-19-research-tools-earlystage-technologies-who-program.html
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html
National Institutes of Health (NIH)
View the latest COVID-19 information from NIH.
https://www.nih.gov/coronavirus

United States Food and Drug Administration (FDA)
•

On May 10, the U.S. Food and Drug Administration provided an at-a-glance
summary of news from around the agency:
o

On May 10, the FDA approved a new indication for Olumiant (baricitinib)
for the treatment of COVID-19 in hospitalized adults requiring
supplemental oxygen, non-invasive or invasive mechanical ventilation, or
extracorporeal membrane oxygenation (ECMO). Olumiant is the first
immunomodulatory treatment for COVID-19 to receive FDA approval.
The FDA first issued an emergency use authorization (EUA) for Olumiant

in combination with remdesivir to treat COVID-19 in hospitalized adults
and pediatric patients on November 19, 2020. On July 28, 2021, the FDA
revised the EUA to authorize Olumiant as a standalone treatment.
Olumiant remains under EUA status for hospitalized pediatric patients 2
to less than 18 years of age requiring supplemental oxygen, non-invasive
or invasive mechanical ventilation, or ECMO. The FDA has revised
the Letter of Authorization and associated fact sheets to remove the
population covered under the approved indication. Common side effects
of Olumiant and the recommended dosage for the approved population
are included in the prescribing information. The FDA continues to work
with developers, researchers, manufacturers, and partners to help
expedite the development and availability of therapeutic drugs and
biological products to prevent or treat COVID-19 through its Coronavirus
Treatment Acceleration Program.
o

On May 10, the FDA issued a safety communication warning people to
not use the Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test
(Colloidal Gold). This test is not authorized, cleared, or approved by the
FDA for distribution or use in the United States. The FDA is concerned
about the risk of false results when using this test because SML
Distribution LLC has not provided the FDA with adequate data to show
the tests work correctly. SML Distribution LLC is recalling the Skippack
Medical Lab SARS-CoV-2 Antigen Rapid Tests (Colloidal Gold), and the
FDA has identified this issue as a Class I recall, the most serious type of
recall.

o

On May10, the FDA posted the refreshed Consumer Update titled Is It
Really ‘FDA Approved’? This article highlights the many ways the FDA is
responsible for protecting the public health by regulating human drugs
and biological products, animal drugs, medical devices, tobacco
products, food (including animal food), cosmetics, and electronic products
that emit radiation.

o

On Monday, the FDA posted warning letters to multiple companies for
selling adulterated dietary supplements that contain, in some cases, new
dietary ingredients (NDIs) for which the FDA has not received the
required premarket NDI notifications and, in others, unsafe food
additives. Some of the identified dietary supplements also are drugs,
despite lacking approval, because they are intended for use in the cure,
mitigation, treatment, or prevention of disease. These products could
potentially harm consumers.

o

On Monday, the FDA issued draft guidance for industry (GFI) #272,
which compiles and describes established practices that medicated feed
manufacturers can use to prevent contamination of animal food from
unsafe drug carryover into other batches of medicated feed or nonmedicated animal food. The FDA will be accepting public comments on
the draft guidance through August 8, 2022. When finalized, GFI #272will

not change the substance of existing policies or introduce new policies.
Rather, it will consolidate much of the information found in two outdated
Compliance Policy Guides and include current animal food regulatory
information and updated examples of factors to consider when designing
sequencing practices.
•

COVID-19 testing updates:
o

As of May10, 433 tests and sample collection devices are authorized by
the FDA under emergency use authorizations (EUAs). These include 298
molecular tests and sample collection devices, 84 antibody and other
immune response tests, 50 antigen tests, and 1 diagnostic breath test.
There are 77 molecular authorizations and 1 antibody authorization that
can be used with home-collected samples. There is 1 EUA for a
molecular prescription at-home test, 2 EUAs for antigen prescription athome

o

The FDA has authorized 28 antigen tests and 7 molecular tests for serial
screening programs. The FDA has also authorized 968 revisions to EUA
authorizations

For the latest overall FDA information about COVID-19.
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/coronavirus-disease-2019-covid-19
Centers for Disease Control and Prevention (CDC)
CDC provides updated information about the variants in the United States- The emerging
variants CDC is closely monitoring have mutations in the virus genome that alter the
characteristics and cause the virus to act differently in ways that are significant to public
health (e.g., causes more severe disease, spreads more easily between humans,
requires different treatments, changes the effectiveness of current vaccines). It’s
important to understand that genetic mutations are expected, and some variants can
spread and become predominant while others subside.
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
CDC provides daily data tracker which has maps and charts tracking cases, deaths, and
trends of COVID-19 in the United States- updated daily by 8 p.m. ET.
https://covid.cdc.gov/covid-data-tracker/#datatracker-home
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html
Center for Medicare and Medicaid Services (CMS) +
View the latest information from CMS

https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/CurrentEmergencies/Current-Emergencies-page
Vaccines
CDC created this section regarding COVID-19 vaccinations in the United States- CDC
provides overall US COVID-19 Vaccine, deliveries and administration, maps, charts, and
data updated daily by 8 p.m. This section represents all vaccine partners including
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal
Emergency Management Agency and Health Resources and Services Administration
partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations
The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the
distribution of the vaccine including the number of doses received by the state, a
breakdown of first or second doses, and the number of persons vaccinated with the first
and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide
updated relevant information including side effects and safety data, clinical trials
demographic statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html
CDC created this section regarding the Moderna vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic statistics,
and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works. As of October 16, 2021, the fully
FDA approved Pfizer vaccine will now be known as COMIRNATY for ages 16 and older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/PfizerBioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
For NYC DOHMH updated guidance regarding COVID-19 vaccine
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19
vaccination location. The Vaccine Finder can also provide New Yorkers with information
to schedule vaccination appointments.
https://vaccinefinder.nyc.gov/

Educational Institution Information
• Higher Education
• Multiple disciplinary organizations have resumed in-person
conferences over the last year. And through a combination of careful
planning and luck, they’ve largely avoided becoming superspreader
events. Even so, the threat of COVID-19 at mass indoor gatherings
remains very real: just ask the 1,900 scholars of human-computer
interaction who gathered in New Orleans from April 30 to May 5—or at
least those who tested positive for the coronavirus during and after the
conference. Some of them are easy to find and have shared their status
and experiences on Twitter under the meeting’s hashtag, #CHI2022.
Others are privately notifying those they were in close contact with during
the event. So how did the Association for Computing Machinery’s CHI
Conference on Human Factors in Computing Systems become a hot spot
for COVID-19 transmission? Event organizers required proof of
vaccination and verified it via a third party; mandated masks except when
eating, drinking or presenting; and planned for social distancing during
meeting sessions. Attendees also agreed to self-monitor for symptoms
and report positive tests to the parent computing association as part of
registration. And because about 1,900 additional attendees opted for the
hybrid conference’s virtual component, the in-person gathering was about
half its typical pre-pandemic size. Read more at
https://www.insidehighered.com/news/2022/05/11/how-scholarlymeeting-became-superspreader-event
• K-12
National per pupil spending crept up ever so slightly between fiscal years 2019 and 2020,
just by 0.7 percent, to $13,489 per student. This was markedly less than the 2.2 percent
increase seen between fiscal 2018 and 2019, the year prior to the pandemic, according to
a new analysis from the U.S. Department of Education’s National Center for Education
Statistics. However, the most recent data only accounts for about three months of COVID19 school closures, and many states had not yet disbursed federal pandemic relief
funds. Read more at https://www.k12dive.com/news/nces-states-entered-pandemic-withsmaller-year-over-year-funding-increases/623573/

Clinical Trials
To view the latest information on clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=
American Red Cross

https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recovered-covid19-patients.html

State Updates

New York
• Governor Kathy Hochul announced the distribution of $28 million in federal pandemic
funding this month to help struggling New Yorkers with children to cover expenses
incurred during the COVID-19 public health emergency. Administered through the state
Office of Temporary and Disability Assistance, the Pandemic Emergency Assistance
Fund will provide families on Public Assistance with a child 17 or younger in their
household with $250 to help pay for housing expenses, bills, and other critical
needs. This assistance follows Governor Hochul's announcement listing resources for
families struggling to obtain formula amid recent shortages. "The economic toll of the
COVID-19 pandemic disproportionately impacted low-income families across our state
- especially those with children," Governor Hochul said. "This one-time payment will
provide tens of thousands of families with a critical lifeline to help pay past-due bills or
other household expenses that accrued as a result of the COVID-19
pandemic." https://www.governor.ny.gov/news/governor-hochul-announces-28-millionassistance-struggling-families-children

New York State Department of Health (DOH)
On May 9, 2022, Governor Hochul updated New Yorkers on the state's progress combating
COVID-19. "As we continue to monitor the numbers, I encourage New Yorkers to keep using the
tools to protect against, treat and prevent serious illness from COVID-19," Governor Hochul said.
"Get your vaccine, your second dose, or your booster when you're eligible and get your children
fully vaccinated. Get tested before traveling and seeing vulnerable loved ones and if you test
positive, ask your doctor about possible treatments. We will continue to make sure these tools
are available to all New Yorkers so we can keep moving forward safely through this pandemic."
https://www.governor.ny.gov/news/governor-hochul-updates-new-yorkers-states-progresscombating-covid-19-253

For a list of positive cases by county in New York Statehttps://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down
cases by county.
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
For the latest COVID-19 information from NYS DOH
https://coronavirus.health.ny.gov/home

New Jersey
• Governor Phil Murphy visited the Hackensack Fire Department to announce the new
American Rescue Plan Firefighter Grant Program, which will help local and regional fire
departments provide first responders with proper protective, cleaning, and sanitization
equipment. The Firefighter Grant Program will enable fire departments to better protect
their employees not just against fires and other hazards on the front lines of emergency
responses, but against deadly pathogens as well. Since the outbreak of COVID-19 in
March 2020, firefighters have faced additional health and safety risks and a growing
need for an array of high-quality equipment, including personal protective equipment
(PPE) and toxic-chemical-free clothing ensembles, helmets, gloves, and boots.
“Confronted by new challenges and obstacles throughout the pandemic, New Jersey’s
firefighters remained unflagging in their commitment to the safety of their

neighbors,” said Governor Murphy. “The American Rescue Plan Firefighter Grant
Program will help New Jersey fulfill its responsibility to these heroes, whose courage
and selflessness in the face of danger demand no less. By launching this program, we
demonstrate our commitment to safety and peace of mind for those who are entrusted
with our protection.” Grants of up to $75,000 will be administered by the Division of Local
Government Services within the Department of Community Affairs, and the program will
be funded by $10 million in American Rescue Plan State Fiscal Recovery Funds. Grant
awards will prioritize volunteer fire departments, as well as departments in communities
that have been disproportionately impacted by the
pandemic. https://nj.gov/governor/news/news/562022/approved/20220516b.shtml
Connecticut
• On May 12, Governor Lamont issued this statement: “Today, our country marks a
heartbreaking milestone – one million American lives lost to COVID-19,” Governor
Lamont said. “To everyone who lost a loved one – whether it be a mother, father, sibling,
child, grandparent, friend, neighbor, or other loved one – I offer my deepest condolences
and pray for each of them. I urge everyone to remain vigilant against this disease. Use
the many tools that are widely available across our state to fight this virus. Get
vaccinated, get boosted. Every day, we are reminded that we are all in this together, and
like any large family, we must look out and care for one another.”
https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2022/052022/Governor-Lamont-Flags-Lowered-To-Half-Staff-in-Remembrance-of-the-OneMillion

Local Updates
New York Blood Center (NYBC)
For the latest updated NYBC information about COVID-19:
https://nybc.org/covid-19/
New York City (NYC) Department of Health and Mental Hygiene (DOHMH)
NYC DOHMH launched a new variants data page. The data on this page show how variants of the
virus that causes COVID-19 are spreading in NYC. Variants are versions of the virus with certain
sets of mutations. Some variants may result in a COVID-19 infection that is easier to spread, more
severe or able to avoid antibodies from vaccines or previous infections.
https://www1.nyc.gov/site/doh/covid/covid-19-data-variants.page
For NYC DOHMH updated COVID-19 data page
https://www1.nyc.gov/site/doh/covid/covid-19-data.page
For the latest COVID-19 information from NYC DOHMH
https://www1.nyc.gov/site/doh/covid/covid-19-main.page
Westchester County Department of Health

For the latest breakdown of positive cases in Westchester County as of May 15, 2022
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d
For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams
offering earlier access to vaccines.
https://health.westchestergov.com/2019-novel-coronavirus
Putnam County Department of Health
Breakdown of positive cases by towns in Putnam County as of May 13, 2022
https://www.putnamcountyny.com/covid19/
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/
Dutchess County Department of Health
Breakdown of positive cases in Dutchess County as of May 16, 2022
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm
Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of May 16, 2022
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information
Rockland County Department of Health
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of
May 13, 2022
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096
For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/
Healthcare
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital
Association that covers hospitals in the tri-state area.
https://www.gnyha.org/

Every effort is made to provide accurate and complete information in this newsletter.
However, New York Medical College cannot guarantee that there will be no errors. NYMC
makes no claims, promises or guarantees about the accuracy, completeness, or adequacy of
the contents of the newsletters or the articles linked herein and further expressly disclaims
liability for errors and omissions in the contents of this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice.
Always seek the advice of your physician or other qualified health provider with any questions
you may have regarding a medical condition.
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